New results from the WHI show that women exposed to combined conjugated estrogens and medroxyprogesterone acetate HRT have an increase in both breast cancer diagnosis and mortality.
Browse by Speciality Area
All Access Subscription
Get unlimited access to our full publication and article library.
Get Access NowInterested in Group Sales? Learn more